OSPEDALE SAN RAFFAELE - Italy 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:300-400
Total Number of Projects:200-300
2019
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:300-400
Total Number of Projects:300-400
2018
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:200-300
Total Number of Projects:100-200
Networking Rank (Reputation):400-500
2017
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Networking Rank (Reputation):300-400
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:300-400
Total Number of Projects:800-900
Networking Rank (Reputation):> 1000
Partner Constancy:500-600
Project Leadership Index:500-600
2012
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2012-01-01 - 2022-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 67
As coordinator: 2
As participant: 41
Sole participant: 24
Coordinator / Participant Ratio: 0.05*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 2.183.473 0 2.183.473 2
2021 2.896.045 7.143.103 4.130.795 4 3
2020 2.187.983 50.569.235 5.419.607 5 10
2019 2.835.876 30.150.625 3.907.126 6 3
2018 6.512.394 40.283.115 7.297.447 6 8
2017 1.833.548 49.906.125 6.933.937 3 8
2016 0 16.730.732 1.600.050 3
2015 0 30.801.022 3.522.939 3
2014 0 4.166.914 3.746.414 2
2012 0 6.000.000 375.000 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE6
UNIVERSITY COLLEGE LONDON6
KATHOLIEKE UNIVERSITEIT LEUVEN5
ACADEMISCH ZIEKENHUIS LEIDEN4
COMMISSARIAT A L'ENERGIE ATOMIQUE4
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM4
KAROLINSKA INSTITUTE4
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN4
MILTENYI BIOTEC4
UNIVERSITA DEGLI STUDI DI MILANO4
EATRIS ERIC3
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA3
INSTITUTO DE SALUD CARLOS III3
ISTITUTO SUPERIORE DI SANITA3
OSPEDALE PEDIATRICO BAMBINO GESU3
POLYTECHNIC OF MILAN3
UNIVERSITAETSKLINIKUM FREIBURG3
UNIVERSITAIR MEDISCH CENTRUM UTRECHT3
UNIVERSITY OF BOLOGNA3
UNIVERSITY OF HELSINKI3
UNIVERSITY OF OSLO3
UNIVERSITY OF SOUTHAMPTON3
ACADEMISCH ZIEKENHUIS MAASTRICHT2
ARTTIC2
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL2
CENTRE DE REGULACIO GENOMICA2
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE2
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
CHARITE UNIVERSITAETSMEDIZIN BERLIN2
CONSIGLIO NAZIONALE DELLE RICERCHE2
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK2
EUROPEAN MOLECULAR BIOLOGY LABORATORY2
FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA2
GENEWERK2
GREAT ORMOND STREET HOSPITAL FOR CHILDREN NHS FOUNDATION TRUST2
IBM ISRAEL SCIENCE AND TECHNOLOGY2
INETUM ESPANA2
INSTITUT CATALA DE LA SALUT2
INSTITUT DE INVESTIGACIO EN CIENCIES DE LA SALUT GERMANS TRIAS I PUJOL2
INTERNATIONAL PATIENT ORGANISATION FOR PRIMARY IMMUNODEFICIENCIES2
KING'S COLLEGE LONDON2
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN2
KUNGLIGA TEKNISKA HOEGSKOLAN2
LIME TECHNOLOGY IKE2
MEDIZINISCHE HOCHSCHULE HANNOVER2
MEDIZINISCHE UNIVERSITAET WIEN2
NESTEC2
POLITECNICO DI MILANO2
POLITECNICO DI TORINO2
REGION HOVEDSTADEN2
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS2
STICHTING KATHOLIEKE UNIVERSITEIT2
STICHTING RADBOUD UNIVERSITEIT2
TECHNISCHE UNIVERSITAET WIEN2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD2
THE PROVOST FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN HEREINAFTER TRINITY COLLEGE DUBLIN2
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA CORP2
UNIVERSITA DEGLI STUDI DEL PIEMONTE ORIENTALE AMEDEO AVOGADRO2
UNIVERSITAET ULM2
UNIVERSITE DU LUXEMBOURG2
UNIVERSITEIT MAASTRICHT2
UNIVERSITY OF AARHUS2
UNIVERSITY OF COPENHAGEN2
UNIVERSITY OF NEWCASTLE UPON TYNE2
UNIVERZA V LJUBLJANI2
UPPSALA UNIVERSITET2
VRIJE UNIVERSITEIT BRUSSEL2
WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTER2
ACADEMIC MEDICAL CENTRE AMSTERDAM1
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACADEMISCH ZIEKENHUIS GRONINGEN1
ACCELOPMENT SCHWEIZ1
ACMIT1
ACROMION1
ADAPTIMMUNE LIMITED1
ADVANCED PRACTICAL DIAGNOSTICS1
AGENCIA DE QUALITAT I AVALUACIO SANITARIES DE CATALUNYA1
AIBILI ASSOCIACAO PARA INVESTIGACAO BIOMEDICA E INNOVACAO EM LUZ E IMAGEM1
ALBERT LUDWIGS UNIVERSITAET FREIBURG1
ALLEANZA CONTRO IL CANCRO1
ALPES LASERS1
ALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES1
ALZHEIMER EUROPE1
AMSTERDAM BIOTHERAPEUTICS UNIT1
ANAXOMICS BIOTECH S L1
ANYSOLUTION SL1
ARGOS MESSTECHNIK1
ARTINESS1
ARTTIC INNOVATION1
ASCEND TECHNOLOGIES LIMITED1
ASSOCIATION MARIE LANNELONGUE1
ATOS SPAIN1
AYUNTAMIENTO DE CALVIA1
AYUNTAMIENTO DE ZARAGOZA1
AZIENDA OSPEDALIEROUNIVERSITARIA MAGGIORE DELLA CARITA NOVARA1
BARTS AND THE LONDON NHS TRUST1
BATAVIA BIOSCIENCES BV1
BAYLOR COLLEGE OF MEDICINE1

Constancy:

Total number of partners: 492
Partner loyalty:
Frequent Partner: (> 2 projects): 81
Rare Partner: 411
Frequent / Rare Partner Ratio: 0.2

Project overview:

Start dateProjectacronymrolefundingpartners
2022-03-01Dissecting and targeting senescence programs to advance Hematopoietic Stem Cell-based gene therapies ReviveSTEMcoordinator2.000.0001
2022-01-01Innovative strategies to increase engraftment of engineered hematopoietic stem cells and bypass genotoxic conditioning, toward the next-generation gene therapy IMPROVING-GTcoordinator183.4731
2021-09-01Exploiting superlongevous model mammals to explore new links between protein and organelle homeostasis and lifespan extension ComBATageingcoordinator183.4731
2021-06-01Short-chain fatty acids in brain neuroinflammation: modulators of immunity and neural stemness BRAINeSscoordinator183.4731
2021-05-01Immune Niches for Cancer ImmunoTherapy Enhancement INCITEparticipant3.998.6658
2021-04-01Minimum viable product for automated 3D imaging reconstruction of the bladder and the bladder cancer AIR3Dparticipant100.0003
2021-03-01Dux4-Regulated Expression and Activity by an inhibitor Molecule DREAMcoordinator183.4731
2021-01-01Immune-privileged, immortal, myogenic stem cells for gene therapy of Muscular Dystrophy. UniMabcoordinator2.345.6251
2021-01-01Autonomous Robotics for Transcatheter dEliveRy sYstems ARTERYparticipant3.044.4388
2020-12-01Creating the 21st century spatial ecosystem FF2020participant5.999.57512
2020-11-01Community-empowered Sustainable Multi-Vector Energy Islands RENergeticparticipant5.959.42614
2020-09-01Endosomal control of local protein synthesis in axons AXONENDOcoordinator1.499.5631
2020-09-01SOmatic MUtagenesis in Kidney Tubule is enhanced by specific metabolic pathways SoMuKTcoordinator183.4731
2020-09-01Photonics for Healthcare: multiscAle cancer diagnosiS and Therapy PHASTparticipant3.939.91814
2020-07-01Targeting ASTROcytes with cutting-edge EDITING technologies to treat the Alexander disease ASTRO-EDITINGcoordinator183.4731
2020-07-01IL-2 gene therapy for chronic hepatitis B virus infection 2LIVErcoordinator150.0001
2020-06-01Beyond 1M Genomes B1MGparticipant4.000.00037
2020-02-01Inhibitor of DUX4-IGH to Erase Acute lymphoblastic Leukaemia IDEALcoordinator171.4731
2020-01-01Human Cell Atlas of the Pancreas ESPACEparticipant4.962.49511
2020-01-01Studying Ciliary Signaling in Development and Disease SCilSparticipant3.844.87411
2020-01-01New Generation Cell Therapy: Bioartificial Pancreas to Cure Type 1 Diabetes VANGUARDparticipant6.844.6259
2020-01-01INnovative Training in Myeloid Regulatory Cell Therapy INsTRuCTparticipant4.021.02714
2020-01-01Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia RECOGNISEDparticipant5.998.27325
2020-01-01Consolidating the capacities of EATRIS-ERIC for Personalised Medicine EATRIS-Plusparticipant4.999.02324
2019-09-01HIstory and IMpact of NEUROimaging on SOCIETY HI_IM_NEUROSOCIETYcoordinator168.2771
2019-08-01Microfluidic chambers for establishing physiological and pathological human iPSC-derived neuronal circuits BrainCircuit-on-chipcoordinator150.0002
2019-06-03"""Investigating autophagy enhancement as a therapeutic approach for the treatment of Rett syndrome.""" RTTOPHAGYcoordinator171.4731
2019-06-01Development of gene therapy and genome editing strategies to treat adenosine deaminase 2 deficiency DADA2GTcoordinator183.4731
2019-03-01Dissecting and Overcoming Innate Immune Barriers for Therapeutically Efficient Hematopoietic Stem Cell Gene Engineering ImmunoStemcoordinator1.994.3751
2019-02-01Uncovering the origin and mechanisms of Down syndrome-associated leukaemia through human induced pluripotent stem cell-derived haemopoiesis LEUKEYOLKcoordinator168.2771
2019-01-01Biomechanics in health and disease: advanced physical tools for innovative early diagnosis Phys2BioMedparticipant3.911.78316
2019-01-01Citizen-centred EU-EHR exchange for personalised health Smart4Healthparticipant21.781.12019
2019-01-01Data-protection toolkit reducing risks in hospitals and care centers ProTegoparticipant4.457.7239
2018-12-01Platform for Innovation of Procurement and Procurement of Innovation PIPPIparticipant2.996.0008
2018-11-01Fact-based personalised nutrition for the young NUTRISHIELDparticipant7.197.09616
2018-11-01Predictive Epigenetics: Fusing Theory and Experiment PEP-NETparticipant4.062.70016
2018-10-01Novel precision technological platforms to promote non-invasive early diagnosis, eradication and prevention of cancer relapse: proof of concept in the bladder carcinoma. EDITcoordinator4.317.1609
2018-10-01Training on Advanced Stem Cell Technologies in Neurology ASCTN-Trainingparticipant3.749.40311
2018-09-17IMaging Pancreatic Alpha-cells Calcium Tied with HEterogeneous Analysis of Labeled Transcription factors with in situ Hybridization IMPACT-HEALTHcoordinator168.2771
2018-07-02Can human embryo-released extracellular vesicles govern endometrial receptivity and inform on vanguard embryo diagnostics and fertility therapeutics? CERVINOcoordinator180.2771
2018-05-16Patroller monocytes as modulators of diabetic retinopathy PAMpeRcoordinator180.2771
2018-03-01Dissecting Cross-Regulatory Interplays in Tumor-Associated Macrophages X-TAMcoordinator1.498.1251
2018-03-01Investigating the effects of immunogenic chemoradiation in shaping the immune landscape of esophageal cancers IC_IL_EC_2017coordinator168.2771
2018-01-01Stem-cell based gene therapy for recombination deficient SCID (RECOMB) RECOMBparticipant5.990.46017
2018-01-01SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherapy of multiple myeloma – a rare hematologic disease CARAMBAparticipant6.097.87511
2018-01-01Immune Signatures for Therapy Stratification in Major Mood Disorders MOODSTRATIFICATIONparticipant5.963.75012
2018-01-01Smart Autonomous Robotic Assistant Surgeon SARASparticipant4.225.8319
2017-12-01Soraprazan - a new regenerative therapy for Stargardt's disease Soraprazanparticipant5.792.4257
2017-11-01Smart-Taylored L-category Electric Vehicle demonstration in hEtherogeneous urbanuse-cases STEVEparticipant7.429.67522
2017-07-01Spatiotemporal dynamics of CD8+ T cell responses to hepatocellular carcinoma Hepatocarcinoma IVMcoordinator168.2771

overview shows latest 50 from 67 projects (2012-01-01 - 2022-12-31)
A full list of projects can be found here: